(Q39570773)

13 September 2017

title

Increased antitumor capability of fiber-modified adenoviral vector armed with TRAIL against bladder cancers (English)

1 reference

13 September 2017

1 reference

Youguang Zhao

1

1 reference

13 September 2017

Ying Li

2

1 reference

13 September 2017

Qingtang Wang

3

1 reference

13 September 2017

Liang Wang

4

1 reference

13 September 2017

Hang Yang

5

1 reference

13 September 2017

Mingli Li

6

1 reference

13 September 2017

publication date

25 March 2011

1 reference

Molecular and Cellular Biochemistry

13 September 2017

published in

1 reference

13 September 2017

volume

353

1 reference

13 September 2017

issue

1-2

1 reference

13 September 2017

page(s)

93-99

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-011-0778-5

13 September 2017

exact match

0 references

cites work

Bladder cancer in 2010: how far have we come?

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

AdCD40L immunogene therapy for bladder carcinoma--the first phase I/IIa trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

Adenovirus delivery of human CD40 ligand gene confers direct therapeutic effects on carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

Clinical adenoviral gene therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

Bladder cancer: can we move beyond chemotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

CD46 is a cellular receptor for group B adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

Evaluation of twenty human adenoviral types and one infectivity-enhanced adenovirus for the therapy of soft tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

Local AdCD40L gene therapy is effective for disseminated murine experimental cancer by breaking T-cell tolerance and inducing tumor cell growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

Tumor-selective replication of an oncolytic adenovirus carrying oct-3/4 response elements in murine metastatic bladder cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

Midkine promoter-based conditionally replicative adenovirus for targeting midkine-expressing human bladder cancer model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

5/35 fiber-modified conditionally replicative adenovirus armed with p53 shows increased tumor-suppressing capacity to breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0778-5

Increased infectivity of adenovirus type 5 bearing type 11 or type 35 fibers to human esophageal and oral carcinoma cells.

21 January 2018

1 reference

12 December 2020

Phase i study of intravesical vaccinia virus as a vector for gene therapy of bladder cancer

1 reference

12 December 2020

Molecular targeting and gene delivery in bladder cancer therapy.

1 reference

12 December 2020

Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy.

1 reference

12 December 2020

Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation

1 reference

12 December 2020

Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells.

1 reference

12 December 2020

A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.

1 reference

12 December 2020

Adenovirus type 5 substituted with type 11 or 35 fiber structure increases its infectivity to human cells enabling dual gene transfer in CD46-dependent and -independent manners

1 reference

12 December 2020

Efficient gene transfer into hematopoietic cells by a retargeting adenoviral vector system with a chimeric fiber of adenovirus serotype 5 and 11p.

1 reference

12 December 2020

10.1007/S11010-011-0778-5

Identifiers

DOI

1 reference

13 September 2017

1 reference